| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000040289 |
| Receipt No. | R000045947 |
| Scientific Title | Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 |
| Date of disclosure of the study information | 2020/05/01 |
| Last modified on | 2020/11/15 (Ver. 5) |
| Basic information | ||
| Public title | Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 | |
| Acronym | Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 | |
| Scientific Title | Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 | |
| Scientific Title:Acronym | Simulation study of tracheal intubation through an aerosol-box assuming COVID-19 | |
| Region |
|
|
| Condition | ||||
| Condition | Patients with infectious diseases assuming COVID-19 | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | The aim of this study is to evaluate the difficulty of intubation through an aerosol-box used for COVID-19 patients and the appropriate device for intubation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Time required to intubate the mannequin |
| Key secondary outcomes | Difficulty of tracheal intubation and mask ventilation, and Cormack grade |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Volunteer doctorss in Tokyo Women's Medical University Hospital | |||
| Key exclusion criteria | doctors who refused to participate | |||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Women's Medical University Hospital | ||||||
| Division name | Department of Intensive Care Medicine | ||||||
| Zip code | 162-8666 | ||||||
| Address | 8-1Kawada-cho, Shinjuku, Tokyo, Japan | ||||||
| TEL | 0333538111 | ||||||
| masafumi203@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Women's Medical University Hospital | ||||||
| Division name | Department of Intensive Care Medicine | ||||||
| Zip code | 162-8666 | ||||||
| Address | 8-1Kawada-cho, Shinjuku, Tokyo, Japan | ||||||
| TEL | 0333538111 | ||||||
| Homepage URL | |||||||
| masafumi203@gmail.com | |||||||
| Sponsor | |
| Institute | Tokyo Women's Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self-funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Women's Medical University |
| Address | 8-1 Kawada-cho, Shinjuku, Tokyo |
| Tel | 0333538111 |
| krinri.bm@twmu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 30 | ||||||
| Results | |||||||
| Results date posted | |||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | |||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | This is a simulation study of tracheal intubation and mask ventilation for mannequins with and without an aerosol-box in doctors at Tokyo Women's Medical University Hospital.
protocol of procedure We ask the participants to perform the intubation using three different devices with and without aerosol box (SplashGuardCG:SGCG), which gives six attempts in each. The orders of procedure are randomized using lottery metod. Intubation devices Macintosh Laryngoscope (ML) (Riester, Jungignen, Germany) with size 3 blade AirWay ScopeTM S-100 (AWS) (Pentax, Tokyo, Japan) McGRATH MACTM (MAC) (Aircraft Medical Ltd., Edinburgh, UK) with size 3 blade Tracheal tube 7.0 mm cuffed tracheal tube (SealGuard EvacTM, Covidien, Dublin, Ireland) stylet (ShileyTM Intubation Stylet, Covidien, Dublin, Ireland) (when intubating with ML and MAC) Simulation manikin Laerdal Airway Management Trainer (Laerdal Medical Japan Ltd., Tokyo, Japan) on the bed in our intensive care unit (ICU) The height of the bed and the pillow, and the position of the manikin are freely adjusted by the participants. Support of procedure The same certified anesthesiologist supports as requested by the subjects, such as inflating a cuff, removing a stylet, or performing the backward upward and rightward pressure (BURP) maneuver through the right holes of aerosol box (SGCG). Intubation time We define the intubation time as the time taken from the participants held the intubation device until the ventilation with bag valve mask via the successfully placed endotracheal tube was confirmed. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000045947 |